title: Chronic plaque psoriasis.
authors.affiliation: Ospedali Riuniti Bergamo, Bergamo, Italy.
authors.forename: Luigi
authors.initials: L
authors.lastname: Naldi
authors.forename: Berthold
authors.initials: B
authors.lastname: Rzany
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000077944:Alefacept; D000875:Anthralin / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000627:therapeutic use; D016207:Cytokines / Q000037:antagonists & inhibitors; D003879:Dermatologic Agents / Q000627:therapeutic use; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D011701:PUVA Therapy; D011565:Psoriasis / Q000188:drug therapy / Q000628:therapy*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D012176:Retinoids / Q000008:administration & dosage / Q000627:therapeutic use; D014467:Ultraviolet Therapy; D014807:Vitamin D / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D016207:Cytokines; D003879:Dermatologic Agents; D009539:Nicotinic Acids; D011993:Recombinant Fusion Proteins; D012176:Retinoids; D014807:Vitamin D; C086827:tazarotene; D016572:Cyclosporine; D000077944:Alefacept; D000875:Anthralin; C472181:efalizumab; D008727:Methotrexate